Infliximab versus cyclosporine as rescue therapy in acute severe steroid-refractory ulcerative colitis: A systematic review and meta-analysis

International Journal of Colorectal Disease

Volumn 28, Issue 3, 2013, Pages 287-293

  Chang, Kah Hoong ^a   Burke, John P ^a   Coffey, J Calvin ^a,b  

^a UNIVERSITY HOSPITAL LIMERICK   (Ireland)

^b UNIVERSITY OF LIMERICK   (Ireland)

Author keywords

Cyclosporine; Infliximab; Meta analysis; Steroid refractory; Ulcerative colitis

Indexed keywords

CYCLOSPORIN; INFLIXIMAB; METHYLPREDNISOLONE; PREDNISOLONE;

ACUTE DISEASE; ADVERSE OUTCOME; CLINICAL EVALUATION; COHORT ANALYSIS; COLON RESECTION; CONTINUOUS INFUSION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SINGLE DRUG DOSE; SYSTEMATIC REVIEW; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT;

ACUTE DISEASE; ANTIBODIES, MONOCLONAL; COLECTOMY; COLITIS, ULCERATIVE; CYCLOSPORINE; HUMANS; POSTOPERATIVE COMPLICATIONS; PUBLICATION BIAS; STEROIDS;

EID: 84878740844     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-012-1602-8     Document Type: Review

References (31)

1. Dinesen LC, Walsh AJ, Protic MN et al (2010) The pattern and outcome of acute severe colitis. J Crohns Colitis 4:431-437
2. Turner D, Walsh C, Steinhart AH, Griffiths AM (2007) Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression. Clin Gastroenterol Hepatol 5:103-110 (Pubitemid 46096828)
3. Tøttrup A, Erichsen R, Sværke C, Laurberg S, Srensen HT (2012) Thirty-day mortality after elective and emergency total colectomy in Danish patients with inflammatory bowel disease: a population-based nationwide cohort study. BMJ Open 2(2):e000823
4. de Silva S, Ma C, Proulx MC, Crespin M, Kaplan BS, Hubbard J (2011) Postoperative complications and mortality following colectomy for ulcerative colitis. Clin Gastroenterol Hepatol 9(11):972-980
5. Lichtiger S, Present DH, Kornbluth A et al (1994) Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Eng J Med 330:1841-1845 (Pubitemid 24188135)
6. D'Haens G, Lemmens L, Geboes K et al (2001) Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis. Gastroenterol 120(6):1323-1329 (Pubitemid 32322305)
7. Rutgeerts P, Sandborn WJ, Feagan BG et al (2005) Infliximab for induction and maintenance therapy for ulcerative colitis. N Eng J Med 353:2462-2476 (Pubitemid 41770166)
8. Kohn A, Prantera C, Pera A, Cosintino R, Sostegni R, Daperno M (2002) Antitumor necrosis factor alpha (infliximab) in the treatment of severe ulcerative colitis: result of an open study on 13 patients. Dig Liv Dis 34:626-630
9. Lees CW, Heys D, Ho GT et al (2007) A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis. Aliment Pharmacol Ther 26:411-419 (Pubitemid 47063146)
10. Aratari A, Papi C, Clemente V et al (2008) Colectomy rate in acute severe ulcerative colitis in the infliximab era. Dig Liv Dis 40:821-826
11. Chey W (2001) Infliximab for patients with refractory ulcerative colitis. Inflamm Bowel Dis 1:s30-s33
12. Kohn A, Daperno M, Armuzzi A et al (2007) Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up. Aliment Pharmacol Ther 26:747-756 (Pubitemid 47246204)
13. Jakobovits SL, Jewell DP, Travis SPL (2007) Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2002 to 2006. Aliment Pharmacol Ther 25:1055-1060 (Pubitemid 46587696)
14. Jarnerot G, Hertevig E, Friis-Liby I et al (2005) Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology 128:1805-1811 (Pubitemid 40824691)
15. Probert CSJ, Hearing SD, Schreiber S et al (2003) Infliximab in moderately severe glucocorticoid-resistant ulcerative colitis: a randomized controlled trial. Gut 52(7):998-1002 (Pubitemid 36765292)
16. Daperno M, Sostegni R, Scaglione N et al (2004) Outcome of a conservative approach in severe ulcerative colitis. Dig Liv Dis 36:21-28 (Pubitemid 41122221)
17. Maser EA, Deconda D, Lichtiger S, Ullman T, Present DH, Kornbluth A (2008) Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis. Clin Gastroenterol Hepatol 6:1112-1116
18. LeBlanc S, Allez M, Seksik P et al (2011) Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitis. Am J Gastroenterol 106:771-777
19. Sjoberg M, Walch A, Meshkat M et al (2012) Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study. Inflamm Bowel Dis 18(2):212-218
20. Dean KE, Hikaka J, Huakau JT, Walmsley RS (2012) Infliximab or cyclosporine for acute severe ulcerative colitis: a retrospective analysis. J Gastroenterol Hepatol 27(3):487-492
21. Mocciaro F, Renna S, Orlando A et al (2012) Cyclosporine or infliximab as rescue therapy in severe refractory ulcerative colitis: early and long-term data from a retrospective observational study. J Crohns Colitis 6:681-686
22. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177-188 (Pubitemid 17189972)
23. Dunne C, Burke JP, Morrow M, Kell MR (2009) Effect on margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol 27(10):1615-1620
24. Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127(9):820-826 (Pubitemid 27465551)
25. Mahid SS, Hornung CA, Minor KS, Turina M, Galanduik S (2006) Systematic reviews and meta-analysis for the surgeon scientist. Br J Surg 93(11):1315-1324 (Pubitemid 44736080)
26. Laharie D, Bourreille A, Branche J et al (2011) Ciclosporin versus infliximab in acute severe ulcerative colitis refractory to intravenous steroids: a randomized study. Gastroenterology 140(S1):S112
27. Selvasekar CR, Cima RR, Larson DW et al (2007) Effect of infliximab on short-term complications in patients undergoing operations for chronic ulcerative colitis. J Am Coll Surg 204(5):956-962 (Pubitemid 46661200)
28. Mor IJ, Vogel JD, da Luz MA, Shen B, Hammel J, Remzi FH (2008) Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy. Dis Colon Rectum 51(8):1202-1207
29. Yang Z, Wu Q, Wu K, Fan D (2010) Meta-analysis: preoperative infliximab treatment and short-term postoperative complications in patients with ulcerative colitis. Aliment Pharmacol Ther 31(4):486-492
30. Truelove SC, Witts LJ 1995 Cortisone in ulcerative colitis: final report on a therapeutic trial. Br Med J 1041-1048
31. Stocchi L (2010) Laparoscopic surgery for ulcerative colitis. Clin Colon Rectal Surg 23(4):248-258